CORE A (Administrative Core)
核心A(行政核心)
基本信息
- 批准号:10407748
- 负责人:
- 金额:$ 10.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-08 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAccountabilityAdministratorAnnual ReportsCancer BiologyCancer CenterCollaborationsCommunicationCommunitiesComprehensive Cancer CenterDiagnosticDoctor of PhilosophyElectronic MailEnsureEsophageal AdenocarcinomaEvaluationEvaluation ResearchExtramural ActivitiesGenetic TranscriptionIndividualInformation TechnologyInfrastructureInstitutesInstitutionJournalsLaboratory ResearchLeadershipMalignant neoplasm of esophagusMeasuresMonitorOffice of Administrative ManagementOperative Surgical ProceduresOrganization administrative structuresPatient advocacyPerformancePrincipal InvestigatorProceduresProcessProgram DevelopmentProgram Research Project GrantsPublicationsPublished CommentReportingResearchResearch ActivityResearch PersonnelResearch Project GrantsResearch SupportResourcesSeriesServicesSiteStructureTelefacsimileTimeTumor BiologyUniversitiesVisitWorkbaseeffectiveness evaluationexperiencemedical schoolsmeetingsmemberoperationorganizational structureprofessorprogramsresearch and developmentresearch data disseminationscientific organizationsenior facultysocial mediasuccesssymposiumtherapy outcometranslational scientisttumorigenesisweb site
项目摘要
ABSTRACT/SUMMARY – Core A (Administrative Core)
The Administrative Core (AC) is based in the Sylvester Comprehensive Cancer Center (Sylvester) at
the University of Miami Miller School of Medicine. The principal investigator of this P01, Wael El-Rifai, MD,
PhD, is the Director of AC and is responsible for the activities of this core. The AC establishes and executes
the scientific and organizational direction and strategy; provides fiscal and administrative oversight,
coordination, and operations management; provides information technology resources to support the research
development and dissemination processes; and assesses the effectiveness and impact of the P01 research
projects and its individual cores. The AC is responsible for managing the P01 resources and facilitating
communications between the P01 components, other collaborators, and with the NCI. This is accomplished
through a series of oversight committees, organized administrative and scientific meetings of P01
investigators, institutional representatives and external advisors. The AC provides organizational structure for
managing the P01 resources and facilitating communications between the P01 components, other
collaborators, and with the NCI. The organizational structure of AC includes two committees to ensure a broad
range of expertise and input into the management process. These include the: 1) Institutional Advisory Board
(IAB), and 2) External Advisory Board (EAB). The AC structure has included several opportunities for scientific
interactions. These include a bi-weekly meeting of project leaders and core directors, weekly laboratories’
research meetings and discussion, a bi-weekly research seminar, a bi-weekly journal club, and an annual
retreat and symposium. In addition, the AC is also responsible for management of communications within the
P01 and between the P01, the Sylvester’s Tumor Biology Program, and the NCI. This will be accomplished
through e-mail, fax, standard mail, and an online web site. Committee reports will be distributed to P01
investigators via these media. Communication to the press, both internal and external, will also be coordinated
through this core. In summary, the AC facilitates key communication, monitoring and oversight services using
built-in committees and measures for accountability, fiscal management, monitoring and evaluation of the
performance of projects and cores.
摘要/摘要 – 核心 A(管理核心)
行政核心 (AC) 位于西尔维斯特综合癌症中心 (Sylvester)
迈阿密大学米勒医学院 P01 的首席研究员 Wael El-Rifai,医学博士,
博士,是 AC 主任,负责该核心的活动。
科学和组织方向及战略提供财政和行政监督;
协调和运营管理;提供信息技术资源以支持研究
开发和传播过程;并评估 P01 研究的有效性和影响
AC 负责管理 P01 资源并提供便利。
P01 组件、其他协作者以及与 NCI 之间的通信已完成。
通过一系列监督委员会,组织了 P01 的行政和科学会议
审计委员会为调查员、机构代表和外部顾问提供组织结构。
管理 P01 资源并促进 P01 组件之间的通信,其他
AC 的组织结构包括两个委员会,以确保广泛的合作。
一系列专业知识和对管理流程的投入包括: 1) 机构顾问委员会。
(IAB),以及 2) 外部顾问委员会 (EAB)。 AC 结构包括多项科学机会。
其中包括每两周一次的项目领导者和核心主任会议、每周一次的实验室会议。
研究会议和讨论、每两周一次的研究研讨会、每两周一次的期刊俱乐部和年度
此外,审计委员会还负责管理内部沟通。
P01 以及 P01、西尔维斯特肿瘤生物学计划和 NCI 之间的合作将会完成。
委员会报告将通过电子邮件、传真、标准邮件和在线网站分发给 P01。
调查人员通过这些媒体与内部和外部媒体的沟通也将得到协调。
总之,审计委员会利用这一核心促进关键的沟通、监测和监督服务。
问责制、财政管理、监测和评估的内置委员会和措施
项目和核心的性能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WAEL EL-RIFAI其他文献
WAEL EL-RIFAI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WAEL EL-RIFAI', 18)}}的其他基金
Intercepting novel functions of AURKA in gastric tumorigenesis
拦截 AURKA 在胃肿瘤发生中的新功能
- 批准号:
10663953 - 财政年份:2022
- 资助金额:
$ 10.98万 - 项目类别:
Disruption of Transcription Networks in Esophageal Adenocarcinoma Tumorigenesis
食管腺癌肿瘤发生中转录网络的破坏
- 批准号:
10407744 - 财政年份:2022
- 资助金额:
$ 10.98万 - 项目类别:
Disruption of Transcription Networks in Esophageal Adenocarcinoma Tumorigenesis
食管腺癌肿瘤发生中转录网络的破坏
- 批准号:
10662298 - 财政年份:2022
- 资助金额:
$ 10.98万 - 项目类别:
Elucidating Novel APE1 Redox-Dependent Functions in Esophageal Adenocarcinoma
阐明食管腺癌中新型 APE1 氧化还原依赖性功能
- 批准号:
10662300 - 财政年份:2022
- 资助金额:
$ 10.98万 - 项目类别:
Elucidating Novel APE1 Redox-Dependent Functions in Esophageal Adenocarcinoma
阐明食管腺癌中新型 APE1 氧化还原依赖性功能
- 批准号:
10407745 - 财政年份:2022
- 资助金额:
$ 10.98万 - 项目类别:
Intercepting novel functions of AURKA in gastric tumorigenesis
拦截 AURKA 在胃肿瘤发生中的新功能
- 批准号:
10515693 - 财政年份:2022
- 资助金额:
$ 10.98万 - 项目类别:
Molecular Functions of CDK1 in Gastric Tumorigenesis
CDK1在胃肿瘤发生中的分子功能
- 批准号:
10546490 - 财政年份:2021
- 资助金额:
$ 10.98万 - 项目类别:
Molecular Functions of CDK1 in Gastric Tumorigenesis
CDK1在胃肿瘤发生中的分子功能
- 批准号:
10117581 - 财政年份:2021
- 资助金额:
$ 10.98万 - 项目类别:
Molecular Functions of CDK1 in Gastric Tumorigenesis
CDK1在胃肿瘤发生中的分子功能
- 批准号:
10326393 - 财政年份:2021
- 资助金额:
$ 10.98万 - 项目类别:
相似国自然基金
问责制度何以影响地方政府绩效——目标责任制情境下的“问责悖论”研究
- 批准号:71103140
- 批准年份:2011
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Automated Detection of Anomalous Accesses to Electronic Health Records
自动检测电子健康记录的异常访问
- 批准号:
7766720 - 财政年份:2009
- 资助金额:
$ 10.98万 - 项目类别:
Automated Detection of Anomalous Accesses to Electronic Health Records
自动检测电子健康记录的异常访问
- 批准号:
8323988 - 财政年份:2009
- 资助金额:
$ 10.98万 - 项目类别: